A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
National Institutes of Health Clinical Center (CC)
CellCentric Ltd.
Ruijin Hospital
Institute of Hematology & Blood Diseases Hospital, China
Weill Medical College of Cornell University
Ruijin Hospital
Peking University
Ohio State University Comprehensive Cancer Center